Pan-immune-inflammation value as a prognostic tool for overall survival and disease-free survival in non-metastatic muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Pan-immune-inflammation value as a prognostic tool for overall survival and disease-free survival in non-metastatic muscle-invasive bladder cancer

Published:2023-09-29 Issue:2 Volume:56 Page:509-518
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Kayar Ridvan^ORCID,Bastug Yavuz^ORCID,Tokuc Emre^ORCID,Topaktas Ramazan^ORCID,Akyurek Elif Atag^ORCID,Kayar Kemal^ORCID,Artuk Ilker^ORCID,Ozturk Metin^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11255-023-03812-w.pdf

Reference29 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209–249

2. Pashos CL, Botteman MF, Laskin BL, Redaelli A (2002) Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract 10(6):311–322

3. Chrouser K, Leibovich B, Bergstralh E, Zincke H, Blute M (2005) Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 174(1):107–110

4. Yu Z, Yue W, Jiuzhi L, Youtao J, Guofei Z, Wenbin G (2018) The risk of bladder cancer in patients with urinary calculi: a meta-analysis. Urolithiasis 46(6):573–579

5. Salem HK, Mahfouz S (2012) Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade. Urology 79(2):379–383

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The predictive impact of hematological inflammatory markers in detecting prostate cancer in patients with PI‐RADS 3 lesions on multiparametric magnetic resonance imaging;The Prostate;2024-06-26

2. The prognostic significance of preoperative platelet-to-lymphocyte ratio and interleukin-6 level in non-muscle invasive bladder cancer;The International Journal of Biological Markers;2024-06-11

3. Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy;Cancers;2024-02-03

4. A Novel Prognostic Model Using Pan-Immune-Inflammation Value and Programmed Death Ligand 1 in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Retrospective Multicenter Analysis;Targeted Oncology;2023-12-02

5. Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?;Medicina;2023-11-22